Clinical Trial Update: Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study evaluating the efficacy and safety of ALLO-ASC-DFU in patients with diabetic foot ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• ALLO-ASC-DFU

Snippet

Sponsor: Anterogen Co., Ltd. | Conditions: Diabetic Foot Ulcer | Phase 2 | Status: COMPLETED